about
Nanosized Drug Delivery Systems in Gastrointestinal Targeting: Interactions with MicrobiotaOpportunistic Sampling of Roadkill as an Entry Point to Accessing Natural Products Assembled by Bacteria Associated with Non-anthropoidal Mammalian Microbiomes.Engineered bacteria can function in the mammalian gut long-term as live diagnostics of inflammation.To engraft or not to engraft: an ecological framework for gut microbiome modulation with live microbes.A transatlantic perspective on 20 emerging issues in biological engineering.Review article: the gut microbiome in inflammatory bowel disease-avenues for microbial management.Small molecule signaling, regulation, and potential applications in cellular therapeutics.A Modular Receptor Platform To Expand the Sensing Repertoire of Bacteria.Complementary and Alternative Medicine Strategies for Therapeutic Gut Microbiota Modulation in Inflammatory Bowel Disease and their Next-Generation Approaches.Synthetic Biology and the Gut Microbiome.A peptide functionalized nanomotor as an efficient cell penetrating tool.Under control: how a dietary additive can restore the gut microbiome and proteomic profile, and improve disease resilience in a marine teleostean fish fed vegetable diets.High efficiency hydrodynamic bacterial electrotransformation.Genetic Engineering of Bee Gut Microbiome Bacteria with a Toolkit for Modular Assembly of Broad-Host-Range Plasmids.An Automated Design Framework for Multicellular Recombinase Logic.Neonatal intestinal dysbiosis in necrotizing enterocolitis.Genome alterations associated with improved transformation efficiency in Lactobacillus reuteri
P2860
Q28069635-E715A266-7CCC-48C0-B5D6-323CFDFFC4DAQ36320795-309228D0-108E-4D5F-A1E9-4A79F78BC145Q40195519-D2B1F7B0-A1ED-4947-8FE5-79163EC7E740Q44401760-3BDA87FD-9774-4199-8EBA-494DC8A35252Q44877018-E391091B-BF9F-4274-97DB-5CE926C8B7A1Q46284784-0CC8EE8F-5BC6-4C23-9993-DB910535187DQ46299026-EB70B3A0-7E00-4264-BCCF-8C429F796B1EQ47634092-EB619497-058A-4FC9-9A90-8881080E7847Q47818880-E93B4A33-6FC4-4E23-BD7A-7263E50CC2A0Q47915556-3A95BAF2-53CA-4548-8C0C-5AC8C9186BA6Q48102133-E16A1211-7468-4833-8A1E-A5C9980A0452Q48340812-4D8FCDC3-8476-46E1-A0DB-A8A99127A7FFQ50962535-7E8E78EC-20C6-4EA1-8770-727975C8A528Q53699396-5152CC61-ADEF-40F1-A012-D635DD612F06Q55363018-AD548135-B289-46F1-A765-5A756F81A730Q55446023-60A3B0D5-FD03-403E-934F-7F3467528818Q58768723-987A5419-F897-4178-AA68-5EDAC82C40FE
P2860
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Microbiome therapeutics - Advances and challenges.
@en
type
label
Microbiome therapeutics - Advances and challenges.
@en
prefLabel
Microbiome therapeutics - Advances and challenges.
@en
P2860
P1476
Microbiome therapeutics - Advances and challenges.
@en
P2093
Mark Mimee
Timothy K Lu
P2860
P356
10.1016/J.ADDR.2016.04.032
P407
P577
2016-05-05T00:00:00Z